While mice succumb to prion disease in their brief lifespans, humans can take decades to manifest symptoms—what underlies this distinction and what insights does it offer for prion disease and potential treatments?
Michael Bordonaro
Michael Bordonaro, PhD, is an associate professor of molecular biology at the Geisinger Commonwealth School of Medicine. Dr. Bordonaro obtained his PhD in the biological sciences from Fordham University in Bronx, New York. Additionally, he completed a postdoctoral fellowship in the Department of Oncology at the Montefiore Medical Center, Bronx, New York. Dr. Bordonaro subsequently held the position of associate research scientist at the Yale University School of Medicine and has also served as a research coordinator for Keren Pharmaceutical. In 2008, Dr. Bordonaro joined the faculty of The Geisinger Commonwealth School of Medicine.